Liming F. Sheng - Publications

Long-Term Outcomes of Concurrent Chemoradiotherapy With S-1 in Older Patients With Esophageal Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA network open

Published: March 27, 2026

Study on the stability of lung cancer radiotherapy dosiomic features under respiratory motion.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: October 16, 2024

Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer.

Journal: Future oncology (London, England)

Published: October 27, 2023

Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.

Journal: BMC cancer

Published: February 21, 2023

Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV).

Journal: Translational lung cancer research

Published: October 21, 2022

Understanding the determinants for predicting citizens' travel mode change from private cars to public transport in China.

Journal: Frontiers in psychology

Published: July 31, 2022

Thyroid Dysfunction as a Predictive Indicator in Camrelizumab of Advanced Esophageal Squamous Cell Carcinoma.

Journal: Journal of immunology research

Published: February 22, 2022

Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer.

Journal: Frontiers in oncology

Published: September 17, 2021

Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial.

Journal: JAMA oncology

Published: August 05, 2021

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World.

Journal: Frontiers in oncology

Published: May 04, 2021

Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma.

Journal: Frontiers in oncology

Published: February 05, 2021

Micropapillary pattern of stage IIIA-N2 lung adenocarcinoma is a prognostic factor after adjuvant chemoradiotherapy.

Journal: Future oncology (London, England)

Published: September 02, 2020